Brief: Inhibrx to host webcast presentation to provide clinical update on INBRX-106 HexAgon study in first line HNSCC
08/05/2026 21:03
May 8 (Reuters) - Inhibrx Biosciences Inc INBX.O: INHIBRX TO HOST WEBCAST PRESENTATION TO PROVIDE CLINICAL UPDATE ON INBRX-106 HEXAGON STUDY IN FIRST LINE HNSCC Source text: ID:nPn53DDr5a Further company coverage: INBX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibrx Biosciences
See all newsInhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study (updated)
Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study
NASDAQ RESUMED AT 08:00 AM
Brief: Inhibrx's Inbrx-106 Nearly Doubles Response Rate And Achieves Interim Median Pfs Of 9.6 Months In Phase 2 Hnscc Study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM